Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.6100 (1.12%) ($41.6100 - $41.6100) on Wed. Jul. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.15% (three month average) | RSI | 32 | Latest Price | $41.6100(1.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.2% a day on average for past five trading days. | Weekly Trend | HALO declines -3.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(50%) IWM(48%) IWC(45%) IWN(44%) | Factors Impacting HALO price | HALO will decline at least -1.075% in a week (0% probabilities). VIXM(-30%) VXX(-11%) UUP(-10%) GLD(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.075% (StdDev 2.15%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $34.45(-17.21%) | Resistance Level | $43.69 | 5 Day Moving Average | $42.06(-1.07%) | 10 Day Moving Average | $42.08(-1.12%) | 20 Day Moving Average | $43.69(-4.76%) | To recent high | -18.7% | To recent low | 7.1% | Market Cap | $5.687b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |